VPC
GSK icon

Vestal Point Capital’s GSK GSK Stock Holding History

Vestal Point Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-125,000
Closed -$5.39M – 94
2025
Q3 		$5.39M Buy
+125,000
New +$4.88M 0.24% 61
2025
Q1 		– Sell
-1,000,000
Closed -$33.8M – 70
2024
Q4 		$33.8M Buy
1,000,000
+700,000
+233% +$25.2M 2.01% 19
2024
Q3 		$12.3M Buy
+300,000
New +$12.3M 0.93% 29

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vestal Point Capital's GSK Position: Q4 2025 in Review

Vestal Point Capital sold out of GSK (GSK) in Q4 2025, closing a stake of 125,000 shares — an estimated $5.39M sold.

Vestal Point Capital first reported a position in GSK in Q3 2024 and held it in 3 quarters. The position peaked at $33.8M in Q4 2024. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • Vestal Point Capital reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
  • Vestal Point Capital sold 125,000 GSK shares in Q4 2025, an estimated $5.39M.
  • Vestal Point Capital first reported a position in GSK in Q3 2024 and held it in 3 quarters.
  • Vestal Point Capital's GSK position peaked at $33.8M in Q4 2024.
  • 995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Vestal Point Capital's 13F filing for Q4 2025, filed 17 Feb 2026.